about
Antioxidants, inflammation and cardiovascular diseaseVitamin E, Turmeric and Saffron in Treatment of Alzheimer's DiseaseNuclear Factor (Erythroid-Derived 2)-Like 2 and Thioredoxin-1 in Atherosclerosis and Ischemia/Reperfusion Injury in the Heart.Coenzyme Q10 and α-tocopherol reversed age-associated functional impairments in mice.Vitamin E isoforms as modulators of lung inflammation.The use of dietary supplements to alleviate androgen deprivation therapy side effects during prostate cancer treatmentAre certain lifestyle habits associated with lower Alzheimer's disease risk?Isoforms of vitamin E differentially regulate inflammation.Tocotrienols reverse cardiovascular, metabolic and liver changes in high carbohydrate, high fat diet-fed rats.Anti-oxidized low-density lipoprotein antibodies in chronic heart failure.Nanotherapeutics for inhibition of atherogenesis and modulation of inflammation in atherosclerotic plaques.Oxidized low-density lipoproteins impair endothelial function by inhibiting non-genomic action of thyroid hormone-mediated nitric oxide production in human endothelial cells.Antioxidants supplementation in elderly cardiovascular patients.Pediatric cardiomyopathies: causes, epidemiology, clinical course, preventive strategies and therapies.Nutritional strategies for dealing with depression.FXR agonists as therapeutic agents for non-alcoholic fatty liver disease.A systematic review of community pharmacist therapeutic knowledge of dietary supplements.Redox-sensitive mechanisms underlying vascular dysfunction in heart failure.Recent advances in the determination of tocopherols in biological fluids: from sample pretreatment and liquid chromatography to clinical studies.α-Tocopherol Stereoisomers in Human Plasma Are Affected by the Level and Form of the Vitamin E Supplement Used.α-Tocopherols modify the membrane dipole potential leading to modulation of ligand binding by P-glycoprotein.Vitamin E ameliorates ox-LDL-induced foam cells formation through modulating the activities of oxidative stress-induced NF-κB pathway.Effect of vitamin E intake from food and supplement sources on plasma α- and γ-tocopherol concentrations in a healthy Irish adult population.Evidence for a hyper-reductive redox in a sub-set of heart failure patients.
P2860
Q26823009-8A9C2345-A245-447B-8D13-682D7BC13D9AQ28080306-2AC6A574-8C09-4235-B509-6541DD793ED0Q30275291-AD1C1361-1F29-4F96-B73E-95531B79B3BFQ30401821-02D19894-4DC0-4AF8-9988-7DCB25FDE3A7Q34382146-36A808CC-BFCC-4AC7-986D-5FC7FD37BB4EQ34411758-76103890-0FAB-4B88-859E-5EEF4E02660CQ35515172-3952B5BE-08CE-4005-91F6-C3EBCB0D74F1Q35734135-4CEB7B16-A6FD-46D7-B0E8-458D4DC85C90Q36395774-BDA87BD1-6F57-43E3-85FC-475D657610DAQ36421852-A0C536E9-8C21-472F-AC92-DD2E56000785Q36496336-8B3DD167-B386-4AE5-9CC2-863FE3628A13Q36603054-C7505E59-9C97-4D70-BE76-DF1DCFBD941DQ37507330-3035FFE2-00EA-42BA-9E1C-B28372B09576Q37520430-5C65F202-E999-4C65-BA34-27B355AB0AB7Q38155089-DAE3A972-A6EC-4C5E-8D5E-3AE4B5B7E771Q38359118-5AE28622-4270-4F9D-B894-4150E38DB5CAQ38375128-591D9426-02B6-4661-AB84-FBADF924CFEBQ38383375-01BCB952-6C64-47E6-B2B2-BF153B356BD9Q38693824-026F1E99-B9DB-4DF0-8F81-B9ABD6810743Q40625705-5CD78F02-E609-4A7D-829F-163458CA3E5CQ42026315-3190CADB-39FF-44B3-901F-4419CE200AD8Q44080476-24CFF526-8871-4C97-838C-0250386EDEC8Q50630189-F595828B-F411-48F7-BE0C-1AEEF724EFD5Q55401731-976C591B-8749-4A94-9637-FDA022E44851
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Vitamin E and cardiovascular disease.
@ast
Vitamin E and cardiovascular disease.
@en
Vitamin E and cardiovascular disease.
@nl
type
label
Vitamin E and cardiovascular disease.
@ast
Vitamin E and cardiovascular disease.
@en
Vitamin E and cardiovascular disease.
@nl
prefLabel
Vitamin E and cardiovascular disease.
@ast
Vitamin E and cardiovascular disease.
@en
Vitamin E and cardiovascular disease.
@nl
P1476
Vitamin E and cardiovascular disease.
@en
P2093
Adonis Saremi
Rohit Arora
P304
P356
10.1097/MJT.0B013E31819CDC9A
P577
2010-05-01T00:00:00Z